
The Samsung scandal played a prominent role in this weeks’ top ten after the South Korean firm was delisted from …

Samsung Biologics has announced it has expanded its strategic alliance with MSD, or Merck as it is known in the …

Sanofi and Hanmi Pharmaceutical have announced a worldwide license agreement to develop a portfolio of experimental, long-acting diabetes treatments. Korea’s …

Eli Lilly and Korean-based pharma firm Hanmi have entered a collaboration agreement to develop and commercialise an immunological therapy. The …

Roche is leaving nothing to chance in its pursuit of the biologics drug market, adding to its internal investment programme …
The chief executive of Johnson & Johnson’s South Korean subsidiary could be facing criminal charges over quality lapses at a …

Johnson & Johnson’s manufacturing network is under yet more scrutiny following regulatory actions by authorities in India and South Korea. …
GlaxoSmithKline has followed through with plans to expand into emerging markets by striking a co-marketing deal with South Korea’s largest …
AstraZeneca has signed another licensing deal to bolster its anti-infectives business, this time signing a deal with Korean company CrystalGenomics …